Economy & Tech2 years ago
EDITORIAL | Like the U.S., Japan Must Quickly Approve Drug for Alzheimer’s
Few manufacturers — such as Japan’s Eisai and the U.S.’ Biogen — have continued to develop a treatment. We hope the health ministry announces the approval...
